298 results on '"Cañueto, J."'
Search Results
2. Estudio longitudinal de los diferentes patrones de progresión en el carcinoma cutáneo de células escamosas de alto riesgo
3. [Translated article] Requirements for Accessing New Dermatology Drugs in Spain: Results of the EQUIDAD Study
4. Condicionantes de acceso a nuevos medicamentos dermatológicos en España: resultados del proyecto EQUIDAD
5. [Translated article] Multicenter Analysis of the Surgical Management and Adjuvant Therapy of Patients With Melanoma and a Positive Sentinel Lymph Node Biopsy
6. Análisis multicéntrico del manejo quirúrgico y tratamiento adyuvante de los pacientes con melanoma y positividad en la biopsia selectiva del ganglio centinela
7. [Translated article] Selection of Quality Indicators for the Certification of Dermato-Oncology Units: The CUDERMA Project Delphi Consensus Study
8. Proyecto CUDERMA: Consenso Delphi de los indicadores de calidad para la certificación de las unidades de dermatología de atención en dermato-oncología
9. [Translated article] Tumor Doubling Time in Skin Cancer: Can It Be Estimated and Is It Useful?
10. ¿Es la estimación del tiempo de duplicación tumoral posible y útil en el cáncer de piel?
11. MicroRNA (miR)‐203 and miR‐205 expression patterns identify subgroups of prognosis in cutaneous squamous cell carcinoma
12. Efficacy and safety of cemiplimab in the treatment of advanced cutaneous squamous cell carcinoma: A multicentre real‐world retrospective study from Spain and systematic review of the published data.
13. Estimated Effect of COVID-19 Lockdown on Skin Tumor Size and Survival: An Exponential Growth Model
14. Estimación del efecto en el tamaño y la supervivencia de los tumores cutáneos debido al confinamiento por COVID-19: modelo basado en un crecimiento exponencial
15. A review of terms used to define cutaneous squamous cell carcinoma with a poor prognosis
16. Revisión de los términos que definen un carcinoma epidermoide cutáneo asociado a mal pronóstico
17. Performance of a new classification system based on the eight most relevant prognostic factors for cutaneous squamous cell carcinoma: a retrospective cohort study showing limits to risk stratification with clinical and histopathological risk factors
18. Identification of two transcriptomic subgroups in actinic keratosis: differentiation between normal skin and cutaneous squamous cell carcinoma-like profiles using RNA-seq
19. Evaluating the performance of a clinicopathological prognostic nomogram and utility of the 40-gene expression profile (40-GEP) test in refining risk of metastasis in high-risk cutaneous squamous cell carcinoma (HR-cSCC) patients
20. Efficacy and safety of tirbanibulin 1% ointment for the treatment of actinic keratosis in routine clinical practice in Spain and Italy (TIRBASKIN study)
21. Patient and physician-reported outcomes with tirbanibulin 1% ointment for actinic keratosis in routine clinical practice in Spain and Italy (TIRBASKIN study)
22. [Translated article] Oral Ruxolitinib could Increase the Aggressiveness of Cutaneous Squamous Cell Carcinomas: A 6-Patient Series
23. Ruxolitinib oral puede aumentar la agresividad de los carcinomas escamosos cutáneos: serie de 6 pacientes
24. The Value of Adjuvant Radiotherapy in Cutaneous Squamous Cell Carcinoma: A Review
25. Utilidad de la radioterapia en adyuvancia en el carcinoma epidermoide cutáneo
26. Condicionantes de acceso a nuevos medicamentos dermatológicos en España: Resultados del proyecto EQUIDAD
27. Novel Additions to the AJCC's New Staging Systems for Skin Cancer
28. Los nuevos sistemas de estadificación del AJCC incorporan novedades en el cáncer cutáneo
29. A-304 - Patient and physician-reported outcomes with tirbanibulin 1% ointment for actinic keratosis in routine clinical practice in Spain and Italy (TIRBASKIN study)
30. Dermatologic Emergencies in a Tertiary Hospital: A Descriptive Study
31. Estudio descriptivo de urgencias dermatológicas en un hospital terciario
32. [[Translated article]]Tumor Doubling Time in Skin Cancer: Can It Be Estimated and Is it Useful?
33. First‐line treatment in lymphomatoid papulosis: a retrospective multicentre study
34. ¿Es la estimación del tiempo de duplicación tumoral posible y útil en el cáncer de piel?
35. Brentuximab vedotin in the treatment of cutaneous T-cell lymphomas: data from the Spanish Primary Cutaneous Lymphoma Registry
36. 728 Multimodal cutaneous squamous cell carcinoma risk stratification tool
37. Novel clinical and molecular findings in Spanish patients with nevoid basal cell carcinoma syndrome
38. Outcome of cutaneous squamous cell carcinoma with microscopic residual disease after surgery and usefulness of postoperative radiotherapy: a retrospective cohort study
39. Novel mutations in FATP4 gene in two families with ichthyosis prematurity syndrome
40. Acral peeling skin syndrome resulting from mutations in TGM5
41. Chronic cutaneous lichenoid graft-versus-host disease at the area of herpes zoster infection and at a vaccination site
42. 1061P Safety of cemiplimab for advanced cutaneous squamous cell carcinoma: The Spanish named patient programme
43. Clinical and epidemiological characteristics of adult patients hospitalized for erysipelas and cellulitis
44. [Translated article] Multicenter Analysis of the Surgical Management and Adjuvant Therapy of Patients With Melanoma and a Positive Sentinel Lymph Node Biopsy
45. CD133+ cell content correlates with tumour growth in melanomas from skin with chronic sun-induced damage
46. Demodicidosis simulating acute graft-versus-host disease after allogeneic stem cell transplantation in one patient with acute lymphoblastic leukemia
47. Clinical, molecular and biochemical characterization of nine Spanish families with Conradi–Hünermann–Happle syndrome: new insights into X-linked dominant chondrodysplasia punctata with a comprehensive review of the literature
48. Effects of COVID-19 Lockdown on Tumour Burden of Melanoma and Cutaneous Squamous Cell Carcinoma
49. 1091P Performance of Salamanca's refinement of the AJCC8 for T3 cutaneous squamous cell carcinoma (CSCC), versus the Brigham and Women's Hospital's alternative staging system and the Tübingen's alternative staging system for high-risk CSCC
50. 1093P The features of the tumour microenvironment and the tumour budding identify prognostic subgroups in high-risk cutaneous squamous cell carcinoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.